← Legislation / NS121
NS121INTRODUCEDHEALTHNOVA SCOTIA

Fair Drug Pricing Act (amended)

Long title not yet sourced from the legislative registry.

Sponsor
—
Introduced
—
Royal assent
—
Final vote
—

Legislative timeline

  1. 1st—
  2. 2nd—
  3. Comm.—
  4. 3rd—
  5. Senate—
  6. Assent—

Bill overview

Bill NS121, “Fair Drug Pricing Act (amended)”, is a Nova Scotia bill from session assembly-63-session-3.

Its latest recorded status is “Introduced”.

This overview is written automatically from the registry and vote records on this page and updates when they sync. It describes the bill's path, not its merits.

PLAIN-LANGUAGE SUMMARY

What you need to know

Status changed: 2021-04-14T00:00:00.000

Key provisions

  1. 01This Act amends the Fair Drug Pricing Act to require pharmaceutical companies to disclose their pricing strategies.
  2. 02The Minister of Health may conduct investigations into the pricing of prescription medications and report the findings to the Assembly.
  3. 03The Minister of Health must establish a list of essential medications and ensure that these medications are available at a reasonable price.
  4. 04Pharmaceutical companies must provide the Minister of Health with information about their pricing and profit margins for certain medications.
  5. 05The Minister of Health may negotiate with pharmaceutical companies to reduce the price of certain medications.

Vote roll

No division has been recorded for this bill yet.